文献速递白血病淋巴瘤

Suz12失活与JAK3突变信号协同促进T细胞急性淋巴细胞白血病发生

Suz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemia.
PubMed 文献 · Blood · 2019-01-01

分析419例T-ALL测序数据发现SUZ12与JAK3突变显著相关,CRISPR/Cas9介导的Suz12失活与突变JAK3协同驱动T细胞转化和T-ALL发生;Suz12失活上调PI3K/mTOR、VEGF和WNT信号,且JAK3/Suz12双突变白血病细胞对HDAC6抑制更敏感。

要点

  • 419例T-ALL中SUZ12与JAK3突变存在显著关联
  • Suz12失活与突变JAK3协同驱动T细胞转化和T-ALL
  • JAK3/Suz12双突变细胞对HDAC6抑制更敏感

核心结论

  • Suz12失活与突变JAK3协同驱动T细胞转化和T-ALL发生。

研究设计与样本

  • 分析419例T-ALL病例的测序数据,并行CRISPR/Cas9介导的Suz12失活与突变JAK3功能实验。
  • 整合基因表达谱、ChIP-seq和ATAC-seq数据,并开展药物筛选。

主要发现

  • 419例T-ALL中SUZ12与JAK3突变呈显著关联。
  • Suz12失活导致PI3K/mTOR、VEGF和WNT信号升高。
  • JAK3/Suz12双突变白血病细胞较JAK3单突变细胞对HDAC6抑制更敏感。
  • 整合分析识别PI3K/mTOR、VEGF/VEGFR和HDAC6/HSP90通路为双突变T-ALL细胞的特定易感靶点。

临床怎么用

  • 对携带JAK3与SUZ12共突变的T-ALL,可考虑HDAC6抑制及靶向PI3K/mTOR、VEGF/VEGFR、HDAC6/HSP90通路的策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The polycomb repressive complex 2, with core components EZH2, SUZ12, and EED, is responsible for writing histone 3 lysine 27 trimethylation histone marks associated with gene repression. Analysis of sequence data from 419 T-cell acute lymphoblastic leukemia (T-ALL) cases demonstrated a significant association between SUZ12 and JAK3 mutations. Here we show that CRISPR/Cas9-mediated inactivation of Suz12 cooperates with mutant JAK3 to drive T-cell transformation and T-ALL development. Gene expression profiling integrated with ChIP-seq and ATAC-seq data established that inactivation of Suz12 led to increased PI3K/mammalian target of rapamycin (mTOR), vascular endothelial growth factor (VEGF), and WNT signaling. Moreover, a drug screen revealed that JAK3/Suz12 mutant leukemia cells were more sensitive to histone deacetylase (HDAC)6 inhibition than JAK3 mutant leukemia cells. Among the broad genome and gene expression changes observed on Suz12 inactivation, our integrated analysis identified the PI3K/mTOR, VEGF/VEGF receptor, and HDAC6/HSP90 pathways as specific vulnerabilities in T-ALL cells with combined JAK3 and SUZ12 mutations.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Broux M, Prieto C, Demeyer S, et al. Suz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemia. Blood. 2019. PMID: 31492675. doi:10.1182/blood.2019000015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。